UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.15 +0.15 (+0.19%) GOLD FUTURES
2,316.10 +5.10 (+0.22%) DOW
38,253.97 +350.68 (+0.93%) Bitcoin GBP
47,473.10 +477.62 (+1.02%)
FibroGen, Inc. (FGEN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:53PM EDT. Market open.
| Previous close | 1.1700 |
| Open | 1.1900 |
| Bid | 1.1600 x 100 |
| Ask | 1.1800 x 300 |
| Day's range | 1.1301 - 1.2300 |
| 52-week range | 0.3330 - 19.4700 |
| Volume | |
| Avg. volume | 1,992,698 |
| Market cap | 116.574M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
- Zacks
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
- Zacks
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.
© 2024 Yahoo. All rights reserved.